Lori J. Pease

2.3k citations

26 papers · 1.5k indexed · 1 hit paper · h-index 19

Molecular Biology top 10%
Cardiology and Cardiovascular Medicine top 5%
Organic Chemistry top 5%
Endocrinology, Diabetes and Metabolism top 5%
Oncology

Co-authors: Dale E. McCall Andrew T. Chiu William F. Herblin Pancras C. Wong Ruth R. Wexler Robert Ardecky David J. Carini A.L. Johnson
Topics: Histone Deacetylase Inhibitors Research (7 papers)Protein Degradation and Inhibitors (6 papers)HER2/EGFR in Cancer Research (5 papers)
Cited by: Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Molecular Biology
Journals: SHILAP Revista de lepidopterologíaCancer Research Biochemical and Biophysical Research Communications
Partner nations: United States United Kingdom Denmark

In The Last Decade

Lori J. Pease

25 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of angiotensin II receptor subtypes

1989 705 citations Andrew T. Chiu, William F. Herblin et al. Biochemical and Biophysical Research Communications profile →

Peers

Countries citing papers authored by Lori J. Pease

Since Specialization

Citations

This map shows the geographic impact of Lori J. Pease's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori J. Pease with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori J. Pease more than expected).

Fields of papers citing papers by Lori J. Pease

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori J. Pease. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori J. Pease. The network helps show where Lori J. Pease may publish in the future.

Co-authorship network of co-authors of Lori J. Pease

This figure shows the co-authorship network connecting the top 25 collaborators of Lori J. Pease. A scholar is included among the top collaborators of Lori J. Pease based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori J. Pease. Lori J. Pease is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence 2024 ·SHILAP Revista de lepidopterología ·(unknown),Lori J. Pease,Hannah O’Keefe,(unknown),Lene Juel Rasmussen,James Wordsworth,Daryl P. Shanley	3
2	Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin,Robin R. Frey,H. Robin Heyman,Niru B. Soni,Patrick A. Marcotte,Lori J. Pease,Keith B. Glaser,Terrance J. Magoc,Paul Tapang,Daniel H. Albert,Donald J. Osterling,Amanda M. Olson,Jennifer J. Bouska,Zhiwen Guan,Lee C. Preusser,James S. Polakowski,Kent D. Stewart,Chris Tse,Steven K. Davidsen,Michael R. Michaelides	19
3	Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yujia Dai,(unknown),Niru B. Soni,Lori J. Pease,David R. Reuter,Amanda M. Olson,Donald J. Osterling,Stella Z. Doktor,Daniel H. Albert,Jennifer J. Bouska,Keith B. Glaser,Patrick A. Marcotte,Kent D. Stewart,Steven K. Davidsen,Michael R. Michaelides	31
4	Thienopyridine urea inhibitors of KDR kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·H. Robin Heyman,Robin R. Frey,Peter F. Bousquet,George A. Cunha,Maria D. Moskey,Asma A. Ahmed,Niru B. Soni,Patrick A. Marcotte,Lori J. Pease,Keith B. Glaser,Melinda S. Yates,Jennifer J. Bouska,Daniel H. Albert,(unknown),Peter J. Dandliker,Kent D. Stewart,Paul Rafferty,Steven K. Davidsen,Michael R. Michaelides,Michael L. Curtin	33
5	ABT-869 a novel multi-targeted receptor tyrosine kinase inhibitor: characterization of FLT3 phosphorylation in a model of acute myelogenous leukemia 2005 ·Cancer Research ·Junling Li,Lori J. Pease,Paul Tapang,Jennifer McCall,(unknown),Daniel H. Albert,Yujia Dai,(unknown),Michael R. Michaelides,Steven K. Davidsen,Keith B. Glaser	0
6	Differential protein acetylation induced by novel histone deacetylase inhibitors 2004 ·Biochemical and Biophysical Research Communications ·Keith B. Glaser,(unknown),Lori J. Pease,Michael J. Staver,Patrick A. Marcotte,Jun Guo,Robin R. Frey,Robert B. Garland,H. Robin Heyman,Carol K. Wada,Anil Vasudevan,(unknown),Steven K. Davidsen,Michael L. Curtin	51
7	Isoindolinone ureas: a novel class of KDR kinase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin,Robin R. Frey,H. Robin Heyman,Kathy Sarris,Douglas H. Steinman,James H. Holmes,Peter F. Bousquet,George A. Cunha,Maria D. Moskey,Asma A. Ahmed,Lori J. Pease,Keith B. Glaser,Kent D. Stewart,Steven K. Davidsen,Michael R. Michaelides	26
8	Indole amide hydroxamic acids as potent inhibitors of histone deacetylases 2003 ·Bioorganic & Medicinal Chemistry Letters ·Yujia Dai,Yan Guo,Jun Guo,Lori J. Pease,Junling Li,Patrick A. Marcotte,Keith B. Glaser,Paul Tapang,Daniel H. Albert,Paul L. Richardson,Steven K. Davidsen,Michael R. Michaelides	34
9	Heterocyclic ketones as inhibitors of histone deacetylase 2003 ·Bioorganic & Medicinal Chemistry Letters ·Anil Vasudevan,Zhiqin Ji,Robin R. Frey,Carol K. Wada,Douglas H. Steinman,H. Robin Heyman,Yan Guo,Michael L. Curtin,Jun Guo,Junling Li,Lori J. Pease,Keith B. Glaser,Patrick A. Marcotte,Jennifer J. Bouska,Steven K. Davidsen,Michael R. Michaelides	33
10	α-Keto amides as inhibitors of histone deacetylase 2003 ·Bioorganic & Medicinal Chemistry Letters ·Carol K. Wada,Robin R. Frey,Zhiqin Ji,Michael L. Curtin,Robert B. Garland,James H. Holms,Junling Li,Lori J. Pease,Jun Guo,Keith B. Glaser,Patrick A. Marcotte,Paul L. Richardson,(unknown),Jennifer J. Bouska,Paul Tapang,Terrance J. Magoc,Daniel H. Albert,Steven K. Davidsen,Michael R. Michaelides	67
11	A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units 2003 ·Bioorganic & Medicinal Chemistry Letters ·Yujia Dai,Yan Guo,Michael L. Curtin,Junling Li,Lori J. Pease,Jun Guo,Patrick A. Marcotte,Keith B. Glaser,Steven K. Davidsen,Michael R. Michaelides	33
12	Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin,Robert B. Garland,H. Robin Heyman,Robin R. Frey,Michael R. Michaelides,Junling Li,Lori J. Pease,Keith B. Glaser,Patrick A. Marcotte,Steven K. Davidsen	97
13	Trifluoromethyl ketones as inhibitors of histone deacetylase 2002 ·Bioorganic & Medicinal Chemistry Letters ·Robin R. Frey,Carol K. Wada,Robert B. Garland,Michael L. Curtin,Michael R. Michaelides,Junling Li,Lori J. Pease,Keith B. Glaser,Patrick A. Marcotte,Jennifer J. Bouska,(unknown),Steven K. Davidsen	116
14	Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzyme 2001 ·Bioorganic & Medicinal Chemistry Letters ·James H. Holms,(unknown),Patrick A. Marcotte,(unknown),Junling Li,Lori J. Pease,Keith B. Glaser,Douglas W. Morgan,Michael R. Michaelides,Steven K. Davidsen	41
15	Enhancement of the surface expression of tumor necrosis factor α (TNFα) but not the p55 TNFα receptor in the THP-1 monocytic cell line by matrix metalloprotease inhibitors 1999 ·Biochemical Pharmacology ·Keith B. Glaser,Lori J. Pease,Junling Li,Douglas W. Morgan	20
16	Expression, release, and regulation of human TNFα from stable transfectants of HEK-293 cells 1997 ·Inflammation Research ·Keith B. Glaser,(unknown),Robert P. Metzger,Thoru Pederson,Lori J. Pease,Kazumi Shiosaki,Douglas W. Morgan	3
17	Role of platelet GPIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release 1994 ·Life Sciences ·Shaker A. Mousa,Jeffrey M. Bozarth,Mark S. Forsythe,(unknown),Lori J. Pease,Thomas M. Reilly	8
18	Inhibition of the thrombin-platelet reactions by DuP 714 1991 ·Biochemical and Biophysical Research Communications ·Andrew T. Chiu,Shaker A. Mousa,Lori J. Pease,(unknown),Jeffrey M. Bozarth,Thomas M. Reilly,Ronald D. Smith,Pieter B.M.W.M. Timmermans	4
19	Angiotensin II Receptor Heterogeneity 1991 ·American Journal of Hypertension ·William F. Herblin,Andrew T. Chiu,Dale E. McCall,Robert Ardecky,David J. Carini,John V. Duncia,Lori J. Pease,Pancras C. Wong,Ruth R. Wexler,A.L. Johnson,Pieter B.M.W.M. Timmermans	50
20	Identification of angiotensin II receptor subtypesbreakdown → 1989 ·Biochemical and Biophysical Research Communications ·Andrew T. Chiu,William F. Herblin,Dale E. McCall,Robert Ardecky,David J. Carini,John V. Duncia,Lori J. Pease,Pancras C. Wong,Ruth R. Wexler,A.L. Johnson,Pieter B.M.W.M. Timmermans	705

About Lori J. Pease

Lori J. Pease is a scholar working on Cancer Research, Hematology and Oncology, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (607 citations), Endocrinology, Diabetes and Metabolism (304 citations) and Molecular Biology (992 citations). Lori J. Pease has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Dale E. McCall, Andrew T. Chiu, William F. Herblin, Pancras C. Wong, Ruth R. Wexler, Robert Ardecky, David J. Carini, A.L. Johnson, John V. Duncia and Pieter B.M.W.M. Timmermans. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact